Department of Cell Biology, Immunology and Physiology, Universitat Autònoma de Barcelona, Spain.
Neurogastroenterol Motil. 2010 Jan;22(1):e34-43. doi: 10.1111/j.1365-2982.2009.01377.x. Epub 2009 Aug 13.
We previously demonstrated that oral chronic exposure to ovalbumin (OVA) causes intestinal hypermotility in Sprague-Dawley rats. In this study, the objective was to determine the mechanism of action of OVA and the role of mucosal mast cells in the regulation of motor activity in this model. Rats were orally exposed to OVA during 6 weeks. Intestinal mucosal mast cells (IMMCs) were counted and rat mast cell protease II (RMCPII) measured in duodenum, jejunum, ileum and colon. Anti-OVA IgE, IgG, and IL-4 were measured in serum. Eosinophils and IgE(+) cells were counted in jejunum. In an additional study rats were treated with the mast cell stabilizer ketotifen and mast cell number, RMCPII concentration and motor activity in vitro were evaluated. OVA exposed rats showed an increase in mucosal mast cell number and in RMCPII content in small intestine and colon. However, variables of a Th(2) type response were not affected by exposure to OVA: (i) neither OVA specific IgE nor IgG were found; (ii) IL-4 did not increase and, (iii) the number of eosinophils and IgE(+) cells was identical in the exposed and unexposed groups. These results brought us to hypothesize a possible non-Ig-mediated action of OVA on mast cells. Ketotifen significantly diminished the response to OVA: Ketotifen reduced the number of mast cells and the RMCPII content and blocked increased intestinal contractility. In addition ketotifen modified motor response in both OVA exposed and unexposed animals giving evidence of the importance of mast cells in intestine motor activity driving.
我们之前的研究表明,口服慢性暴露于卵清蛋白(OVA)会导致 Sprague-Dawley 大鼠肠道蠕动过度。本研究旨在确定 OVA 的作用机制以及黏膜肥大细胞在该模型中调节运动活性的作用。大鼠在 6 周内口服暴露于 OVA。计数十二指肠、空肠、回肠和结肠中的肠黏膜肥大细胞(IMMC),并测量大鼠肥大细胞蛋白酶 II(RMCPII)。测量血清中的抗 OVA IgE、IgG 和 IL-4。计数空肠中的嗜酸性粒细胞和 IgE(+)细胞。在另一项研究中,用肥大细胞稳定剂酮替芬处理大鼠,并评估肥大细胞数量、RMCPII 浓度和体外运动活性。OVA 暴露大鼠表现出黏膜肥大细胞数量增加和小肠和结肠 RMCPII 含量增加。然而,OVA 暴露对 Th(2)型反应的变量没有影响:(i)未发现 OVA 特异性 IgE 或 IgG;(ii)IL-4 没有增加,(iii)暴露组和未暴露组的嗜酸性粒细胞和 IgE(+)细胞数量相同。这些结果使我们假设 OVA 对肥大细胞可能存在非 Ig 介导的作用。酮替芬显著降低了对 OVA 的反应:酮替芬减少了肥大细胞数量和 RMCPII 含量,并阻断了肠道收缩性的增加。此外,酮替芬改变了暴露和未暴露动物的运动反应,证明了肥大细胞在肠道运动活性驱动中的重要性。